Universität Wien

301407 VO DNA-Tumor Viruses, from Cancer Agent to therapy (2019W)

Elective Course in Molecular Medicine

2.00 ECTS (1.00 SWS), SPL 30 - Biologie
Moodle

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Register/Deregister for this course

Details

Language: English

Examination dates

Lecturers

Classes (iCal) - next class is marked with N

BZB/SR 1, Dr. Bohr-Gasse 9/6.Stock, 1030 Wien.
Termine: 20., 21., 27., 28.11., 4., und 5.12. jeweils von 11-13Uhr
Prüfung: 15.1.2020 10-11Uhr
Department für Med.Biochemie der MedUniWien, BZB, Dr. Bohr-Gasse 9, 1030 Wien.
Siehe auch Studentenseite der Departments: http://molekularebiologie.univie.ac.at/

  • Wednesday 20.11. 11:00 - 13:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Thursday 21.11. 11:00 - 13:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Wednesday 27.11. 11:00 - 13:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Thursday 28.11. 11:00 - 13:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Wednesday 04.12. 11:00 - 13:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
  • Thursday 05.12. 11:00 - 13:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien

Information

Aims, contents and method of the course

DNA tumour viruses play not only an import role as human pathogens causing diseases like cervical cancer but also serve as important tools to elucidate basic mechanisms of cancerogenesis. For example, the tumour suppressor protein p53 was discovered as a cellular protein of 53kDa targeted and inactivated by the large tumour antigen (LT) of the DNA tumour virus SV40. More recently, a novel anti-cancer strategy was developed based on the lytic function of DNA tumour viruses (e.g. ONYX015).
The lecture will include the following topics:
Classification of DNA tumour viruses
Lytic and transformation cycle
Viral oncoproteins and their cellular targets: p53, pRB (the retinoblastoma gene product), protein phosphatase 2A (PP2A) and others
Human Papillomavirus and the development of cervical carcinoma
Cancer therapy with adenovirus mutants

Assessment and permitted materials

Written exam
Due to the Covid-19 measures, the exam will be held in SS 2020 in digital form.

Minimum requirements and assessment criteria

50%

Examination topics

Reading list

Association in the course directory

MMB IV-2, MMB IV-3, MMB W-2, MMEI III, UF MA BU 01, UF MA BU 04

Last modified: Fr 12.05.2023 00:24